1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients
    Journal Article

    Suzuki, K.; Kadota, K.; Sima, C. S.; Sadelain, M.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
    Cancer Immunology, Immunotherapy (2011)

    Fulltext@MSK | Save
  • Electronic chemotherapy order entry: A major cancer center's implementation
    Journal Article

    Sklarin, N. T.; Granovsky, S.; O'Reilly, E. M.; Zelenetz, A. D.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save
  • Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
    Journal Article

    Löwenberg, B.; Muus, P.; Ossenkoppele, G.; Rousselot, P.; Cahn, J. Y.; Ifrah, N.; Martinelli, G.; Amadori, S.; Berman, E.; Sonneveld, P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia
    Journal Article

    Leder, K.; Foo, J.; Skaggs, B.; Gorre, M.; Sawyers, C. L.; Michor, F.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): A phase 3 biological assignment trial
    Journal Article

    Krishnan, A.; Pasquini, M. C.; Logan, B.; Stadtmauer, E. A.; Vesole, D. H.; Alyea, E.; Antin, J. H.; Comenzo, R.; Goodman, S.; Hari, P.; more...
    Lancet Oncology (2011)

    Fulltext@MSK | Save
  • It dices, it splices!
    Journal Article

    Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Donor-derived lymphomatoid papulosis in a stem-cell transplantation recipient
    Journal Article

    Camp, B. J.; Busam, K. J.; Brownell, I.; Koehne, G.; Hedvat, C.; Pulitzer, M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
    Journal Article

    Bograd, A. J.; Suzuki, K.; Vertes, E.; Colovos, C.; Morales, E. A.; Sadelain, M.; Adusumilli, P. S.
    Cancer Immunology, Immunotherapy (2011)

    Fulltext@MSK | Save
  • Synthesis of fluorinated analogs of abiraterone, a mechanism-based inhibitor of CYP17A1 for castration resistant prostate cancer therapy
    Meeting Abstract

    Veach, D. R.; Evans, M.; Sawyers, C. L.; Larson, S. M.
    Journal of Labelled Compounds and Radiopharmaceuticals (2011)

    Fulltext@MSK | Save
  • Entecavir is effective in preventing Hepatitis B reactivation in cancer patients receiving chemotherapy
    Meeting Abstract

    Mendelsohn, R. B.; Ng, G.; Patel, D.; Taur, Y.; Kamboj, M.; Zelenetz, A. D.; Sepkowitz, K.; Ludwig, E.
    Hepatology (2011)

    Fulltext@MSK | Save